Annual Drug Patent Expirations for JYLAMVO
Jylamvo is a drug marketed by Therakind and is included in one NDA. There is one patent protecting this drug.
This drug has sixteen patent family members in seventeen countries.
The generic ingredient in JYLAMVO is methotrexate. Additional details are available on the methotrexate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
